The Possible of Immunotherapy for COVID-19: a Systematic Review
Identifieur interne : 000017 ( Pmc/Checkpoint ); précédent : 000016; suivant : 000018The Possible of Immunotherapy for COVID-19: a Systematic Review
Auteurs : Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran]Source :
- International Immunopharmacology [ 1567-5769 ] ; 2020.
Abstract
The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV. These methods include several types of vaccines, monoclonal antibody candidates, and etc. This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV. As a conclusion of these studies demonstrated that although no serious research has been done on this subject at the time of writing this article, similar studies on the coronaviruses showed notable results. So immunotherapy for COVID-19 virus can also be a suitable option.
Url:
DOI: 10.1016/j.intimp.2020.106455
PubMed: 32272396
PubMed Central: 7128194
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7128194Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Possible of Immunotherapy for COVID-19: a Systematic Review</title><author><name sortKey="Aminjafari, Akram" sort="Aminjafari, Akram" uniqKey="Aminjafari A" first="Akram" last="Aminjafari">Akram Aminjafari</name><affiliation wicri:level="1"><nlm:aff id="af005">Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation></author><author><name sortKey="Ghasemi, Sorayya" sort="Ghasemi, Sorayya" uniqKey="Ghasemi S" first="Sorayya" last="Ghasemi">Sorayya Ghasemi</name><affiliation wicri:level="1"><nlm:aff id="af010">Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af015">Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32272396</idno><idno type="pmc">7128194</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128194</idno><idno type="RBID">PMC:7128194</idno><idno type="doi">10.1016/j.intimp.2020.106455</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">001347</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001347</idno><idno type="wicri:Area/Pmc/Curation">001347</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001347</idno><idno type="wicri:Area/Pmc/Checkpoint">000017</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000017</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Possible of Immunotherapy for COVID-19: a Systematic Review</title><author><name sortKey="Aminjafari, Akram" sort="Aminjafari, Akram" uniqKey="Aminjafari A" first="Akram" last="Aminjafari">Akram Aminjafari</name><affiliation wicri:level="1"><nlm:aff id="af005">Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation></author><author><name sortKey="Ghasemi, Sorayya" sort="Ghasemi, Sorayya" uniqKey="Ghasemi S" first="Sorayya" last="Ghasemi">Sorayya Ghasemi</name><affiliation wicri:level="1"><nlm:aff id="af010">Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af015">Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran</nlm:aff><country xml:lang="fr">Iran</country><wicri:regionArea>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord</wicri:regionArea><wicri:noRegion>Shahrekord</wicri:noRegion></affiliation></author></analytic><series><title level="j">International Immunopharmacology</title><idno type="ISSN">1567-5769</idno><idno type="eISSN">1878-1705</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="o0005"><label>•</label><p id="p0005">The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV.</p></list-item><list-item id="o0010"><label>•</label><p id="p0010">These methods include several types of vaccines, monoclonal antibody candidates, and etc.</p></list-item><list-item id="o0015"><label>•</label><p id="p0015">This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV.</p></list-item><list-item id="o0020"><label>•</label><p id="p0020">As a conclusion of these studies demonstrated that although no serious research has been done on this subject at the time of writing this article, similar studies on the coronaviruses showed notable results.</p></list-item><list-item id="o0025"><label>•</label><p id="p0025">So immunotherapy for COVID-19 virus can also be a suitable option.</p></list-item></list></p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Shanmugaraj, B" uniqKey="Shanmugaraj B">B. Shanmugaraj</name></author><author><name sortKey="Malla, A" uniqKey="Malla A">A. Malla</name></author><author><name sortKey="Phoolcharoen, W" uniqKey="Phoolcharoen W">W. Phoolcharoen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Malik, Y S" uniqKey="Malik Y">Y.S. Malik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shanmugaraj, B" uniqKey="Shanmugaraj B">B. Shanmugaraj</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Tian, X" uniqKey="Tian X">X. Tian</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, Q" uniqKey="Zhang Q">Q. Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tai, W" uniqKey="Tai W">W. Tai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baruah, V" uniqKey="Baruah V">V. Baruah</name></author><author><name sortKey="Bose, S" uniqKey="Bose S">S. Bose</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, N" uniqKey="Zhang N">N. Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ahmed, S F" uniqKey="Ahmed S">S.F. Ahmed</name></author><author><name sortKey="Quadeer, A A" uniqKey="Quadeer A">A.A. Quadeer</name></author><author><name sortKey="Mckay, M R" uniqKey="Mckay M">M.R. McKay</name></author></analytic></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Int Immunopharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Int. Immunopharmacol</journal-id><journal-title-group><journal-title>International Immunopharmacology</journal-title></journal-title-group><issn pub-type="ppub">1567-5769</issn><issn pub-type="epub">1878-1705</issn><publisher><publisher-name>Elsevier B.V.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32272396</article-id><article-id pub-id-type="pmc">7128194</article-id><article-id pub-id-type="publisher-id">S1567-5769(20)30912-7</article-id><article-id pub-id-type="doi">10.1016/j.intimp.2020.106455</article-id><article-id pub-id-type="publisher-id">106455</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Possible of Immunotherapy for COVID-19: a Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author" id="au005"><name><surname>AminJafari</surname><given-names>Akram</given-names></name><xref rid="af005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au010"><name><surname>Ghasemi</surname><given-names>Sorayya</given-names></name><email>sorayya.ghasemi@gmail.com</email><xref rid="af010" ref-type="aff">b</xref><xref rid="af015" ref-type="aff">c</xref><xref rid="fn1" ref-type="fn">1</xref><xref rid="cor1" ref-type="corresp">⁎</xref></contrib></contrib-group><aff id="af005"><label>a</label>Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran</aff><aff id="af010"><label>b</label>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran</aff><aff id="af015"><label>c</label>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran</aff><author-notes><corresp id="cor1"><label>⁎</label>Corresponding Author: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran <email>sorayya.ghasemi@gmail.com</email></corresp><fn id="fn1"><label>1</label><p id="np005">Postal address: Cellular-Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Postal code: 8813833435 Shahrekord, Rahmatiyeh, Iran.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>2</day><month>4</month><year>2020</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="epub"><day>2</day><month>4</month><year>2020</year></pub-date><elocation-id>106455</elocation-id><history><date date-type="received"><day>25</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>© 2020 Elsevier B.V. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier B.V.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract abstract-type="author-highlights" id="ab005"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="o0005"><label>•</label><p id="p0005">The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV.</p></list-item><list-item id="o0010"><label>•</label><p id="p0010">These methods include several types of vaccines, monoclonal antibody candidates, and etc.</p></list-item><list-item id="o0015"><label>•</label><p id="p0015">This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV.</p></list-item><list-item id="o0020"><label>•</label><p id="p0020">As a conclusion of these studies demonstrated that although no serious research has been done on this subject at the time of writing this article, similar studies on the coronaviruses showed notable results.</p></list-item><list-item id="o0025"><label>•</label><p id="p0025">So immunotherapy for COVID-19 virus can also be a suitable option.</p></list-item></list></p></abstract><abstract id="ab010"><p>The novel coronavirus (2019-nCoV) is an emerging pathogen that was first described in late December 2019 and causes a severe respiratory infection in humans. Since the outbreak of COVID-19, international attention has raised to develop treatment and control options such as types of immunotherapies.</p><p>The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV. These methods include several types of vaccines, monoclonal antibody candidates, and etc.</p><p>This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV. Web of Science (ISI), PubMed, and Scopus databases were used to search for suitable keywords such as 2019-nCoV, novel coronavirus, Immunotherapy, interleukin, vaccine and the related words for relevant publications up to 24.3.2020. The present systematic review was performed based on PRISMA protocol. Data extraction and quality valuation of articles were performed by two reviewers. 51 articles were the results of the search and based on the inclusions and exclusions criteria, 7 articles were included in the final review.</p><p>As a conclusion of these studies demonstrated that although no serious research has been done on this subject at the time of writing this article, similar studies on the related viruses showed notable results. So immunotherapy for this virus can also be a suitable option.</p></abstract><kwd-group id="kg005"><title>Keywords</title><kwd>2019-nCoV</kwd><kwd>COVID-19</kwd><kwd>Immunotherapy</kwd><kwd>monoclonal antibody</kwd><kwd>vaccine</kwd><kwd>interleukin</kwd></kwd-group></article-meta></front></pmc><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Aminjafari, Akram" sort="Aminjafari, Akram" uniqKey="Aminjafari A" first="Akram" last="Aminjafari">Akram Aminjafari</name></noRegion><name sortKey="Ghasemi, Sorayya" sort="Ghasemi, Sorayya" uniqKey="Ghasemi S" first="Sorayya" last="Ghasemi">Sorayya Ghasemi</name><name sortKey="Ghasemi, Sorayya" sort="Ghasemi, Sorayya" uniqKey="Ghasemi S" first="Sorayya" last="Ghasemi">Sorayya Ghasemi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000017 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000017 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:7128194
|texte= The Possible of Immunotherapy for COVID-19: a Systematic Review
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:32272396" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |